ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 582,74
-0,65%
Dow Jones
40 726,60
1,28%
DAX
18 528,77
-0,38%
Brent Oil
83,425
-1,08%
Bitcoin
64 741,85
-0,17%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Summit Therapeutics Inc (SMMT)

  7. Summit Therapeutics Inc (SMMT) Actualités

SMMT

Summit Therapeutics (SMMT)

Summit Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SMMT
DateHeureSourceTitreSymboleSociété
29/08/201813h00GlobeNewswire Inc.Summit Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment ConferenceNASDAQ:SMMTSummit Therapeutics Inc
16/08/201814h59Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
16/08/201813h00GlobeNewswire Inc.Summit Awarded Additional $12 Million by BARDA for Phase 3 Development Programme of Ridinilazole for the Treatment of C. diff...NASDAQ:SMMTSummit Therapeutics Inc
06/08/201813h00GlobeNewswire Inc.Summit Therapeutics to Present at the Canaccord Genuity Growth ConferenceNASDAQ:SMMTSummit Therapeutics Inc
02/08/201820h00GlobeNewswire Inc.Phase 2 Clinical Data Published Showing Summit’s Ridinilazole Preserved the Gut Microbiome of Patients with C. difficile In...NASDAQ:SMMTSummit Therapeutics Inc
30/07/201816h47PR Newswire (US)Summit Therapeutics Joins Antimicrobials Working GroupNASDAQ:SMMTSummit Therapeutics Inc
28/06/201823h06Dow Jones NewsADRs End HigherNASDAQ:SMMTSummit Therapeutics Inc
27/06/201813h00GlobeNewswire Inc.Summit Announces PhaseOut DMD Did Not Meet Primary EndpointNASDAQ:SMMTSummit Therapeutics Inc
15/06/201813h00GlobeNewswire Inc.Summit Therapeutics to Present at the JMP Securities Life Sciences ConferenceNASDAQ:SMMTSummit Therapeutics Inc
11/06/201813h00GlobeNewswire Inc.Summit Unveils Second Novel Target for Gonorrhoea at ASM Microbe 2018NASDAQ:SMMTSummit Therapeutics Inc
05/06/201813h00GlobeNewswire Inc.Summit Therapeutics Reports Financial Results for the First Quarter Ended 30 April 2018 and Operational ProgressNASDAQ:SMMTSummit Therapeutics Inc
01/06/201813h00GlobeNewswire Inc.Summit Therapeutics Provides Notice of Financial Results for the First Quarter Ended 30 April 2018NASDAQ:SMMTSummit Therapeutics Inc
30/05/201812h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SMMTSummit Therapeutics Inc
15/05/201822h49Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:SMMTSummit Therapeutics Inc
09/05/201819h59Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:SMMTSummit Therapeutics Inc
23/04/201813h00GlobeNewswire Inc.Summit Highlights Discovery of a Series of New Mechanism Antibiotics for the Treatment of Gonorrhoea in Late-Breaking Present...NASDAQ:SMMTSummit Therapeutics Inc
23/04/201812h45GlobeNewswire Inc.Award of Share Options and Restricted Stock UnitsNASDAQ:SMMTSummit Therapeutics Inc
20/04/201813h00GlobeNewswire Inc.Summit Presents New 24-Week Analyses from PhaseOut DMD at the 2018 American Academy of Neurology Annual MeetingNASDAQ:SMMTSummit Therapeutics Inc
19/04/201813h00GlobeNewswire Inc.Summit Completes Dosing of Ezutromid in PhaseOut DMD Clinical TrialNASDAQ:SMMTSummit Therapeutics Inc
13/04/201815h08Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:SMMTSummit Therapeutics Inc
11/04/201813h00GlobeNewswire Inc.Summit Therapeutics Reports Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2018 and Operational Pr...NASDAQ:SMMTSummit Therapeutics Inc
09/04/201816h01GlobeNewswire Inc.Summit Therapeutics Provides Notice of Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2018NASDAQ:SMMTSummit Therapeutics Inc
05/04/201813h00GlobeNewswire Inc.Summit Therapeutics to Present at the H.C. Wainwright Global Life Sciences ConferenceNASDAQ:SMMTSummit Therapeutics Inc
28/03/201813h00GlobeNewswire Inc.Summit Therapeutics Selected for Emerging Science Presentation at the 2018 American Academy of Neurology Annual MeetingNASDAQ:SMMTSummit Therapeutics Inc
27/03/201813h00GlobeNewswire Inc.Summit Therapeutics Announces Placement of £15.0 Million of Ordinary SharesNASDAQ:SMMTSummit Therapeutics Inc
14/03/201812h00GlobeNewswire Inc.Summit Highlights Scientific Rigour of its PhaseOut DMD Clinical Trial at MDA Clinical ConferenceNASDAQ:SMMTSummit Therapeutics Inc
13/03/201812h00GlobeNewswire Inc.Summit’s Infectious Diseases Technology Platform Yields Novel Antibiotics with Potential in Global Fight Against Gonorrhoea...NASDAQ:SMMTSummit Therapeutics Inc
07/03/201813h00GlobeNewswire Inc.Summit Expands Enrolment in PhaseOut DMD Phase 2 Clinical Trial to Include Planned Additional GroupNASDAQ:SMMTSummit Therapeutics Inc
26/02/201813h00GlobeNewswire Inc.Summit Announces New Analysis Showing Ezutromid Significantly Reduced Muscle Inflammation in Phase 2 Clinical Trial in DMDNASDAQ:SMMTSummit Therapeutics Inc
23/02/201813h00GlobeNewswire Inc.Summit Therapeutics to Participate in 2018 BTIG Healthcare ConferenceNASDAQ:SMMTSummit Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SMMT

Dernières Valeurs Consultées

LSE
0KGB
Patterson Companies
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés